Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Phytogenic
  • Carcinoma
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms
  • Vinblastine

abstract

  • NVB is an effective, palliative agent for women with recurrent EOC. Dose-limiting granulocytopenia is substantial, yet manageable.

publication date

  • February 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1006/gyno.1998.5243

PubMed ID

  • 10021293

Additional Document Info

start page

  • 148

end page

  • 53

volume

  • 72

number

  • 2